from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3708c/asd

LFCtreatmentdescriptionclass of inhibitor

-1.163

Amikacinug/mL Amikacintranslation

-1.665

Cap5-10ug/mL Capreomycintranslation

-1.871

Rox10-50 ug/mL Roxithromycintranslation

-0.025

SM2-5 ug/mL Streptomycintranslation

-1.779

Tet5-10 ug/mL Tetracyclinetranslation

-0.044

Rif0.2-5ug/mL Rifampicintranscription

-0.049

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.462

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.186

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.146

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.131

Clofazimine10-13 ug/mL Clofaziminerespiration

0.052

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.757

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.404

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.070

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.112

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.351

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.263

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.466

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.438

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.181

KCN5-20 ug/mL Potassium cyaniderespiration

1.300

NaN30.2-2 mM Sodium aziderespiration

-1.056

Nigericin50 uM Nigericinrespiration

-0.376

TRC10-150 ug/mL Triclosanrespiration

-1.314

TRZ10-25 ug/mL Thioridazinerespiration

-2.181

Valinomycin0.5-10 uM Valinomycinrespiration

0.067

ZnSO42 mM ZnSO4respiration

-0.042

menadione6-10 ug/mL Menadionerespiration

-0.275

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.068

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.467

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.333

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.381

NRP_1Non-replicating persistence stage 1dosRassociated

0.444

Amp0.2mg/mL AmpicillincellWall

-0.203

Cephalexin20-100 ug/mL CephalexincellWall

-0.160

Cerulenin0.32-5 ug/mL CerulenincellWall

0.525

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.403

EMB10-20 ug/mL EthambutolcellWall

0.528

Eta12-40 ug/mL EthionamidecellWall

0.489

INH0.2-0.4 ug/mL IsoniazidcellWall

0.713

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.241

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.124

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.107

BZA0.12 mg/mL BenzamidearomaticAmides

0.342

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.167

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.426

H2O24 mM hydrogen peroxideDNAdamaging

-0.603

Levo10 ug/mL LevofloxacinDNAdamaging

0.408

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.346

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.082

UVUV-irradiationDNAdamaging

-0.251

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.130

Antimycin12.5-50 ug/mL Antimycin A?

-0.545

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.291

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.228

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.137

PA8240.2-2 ug/mL PA-824?

1.573

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.465

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.844

Verapamil50 uM Verapamil?

-0.531

mercaptoethanol2 mM 2-Mercaptoethanol?

0.033

methoxatin10-20 ug/mL Methoxatin?